The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Naloxone Hydrochloride 400 micrograms/ml Solution for Injection or Infusion

Mercury Pharmaceuticals (Ireland) LtdPA0073/111/002

Main Information

Trade NameNaloxone Hydrochloride 400 micrograms/ml Solution for Injection or Infusion
Dosage FormSolution for injection/infusion
Licence HolderMercury Pharmaceuticals (Ireland) Ltd
Licence NumberPA0073/111/002

Group Information

ATC CodeV03AB Antidotes
V03AB15 naloxone


License statusAuthorised
Licence Issued03/10/1989
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back